WHO ICTRP trial
Inhaled sedation in the critically ill patient
CTIS2024-518521-14-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-518521-14-00 |
|---|---|
| Public title | Inhaled sedation in the critically ill patient |
| Scientific title | Inhaled sedation in the critically ill patient: a multicentre randomised clinical trial - SI-CRITIC |
| Primary sponsor | Hospital Universitario La Paz |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Spain |
| Conditions | Critical condition;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] |
| Interventions | Product Name: Propofol Fresenius 20 mg/ml emulsión para inyección o perfusión, Product Code:PRD685068, Pharmaceutical Form: EMULSION FOR INJECTION/INFUSION, Other descriptive name: , Strength: , Product Name: Sedaconda 100% líquido para… |
| Registration date | Nov 22, 2024 |
| Target size | 620 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: